Recap: OptimizeRx Q2 Earnings - OptimizeRx (NASDAQ:OPRX)

OptimizeRx OPRX reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

OptimizeRx missed estimated earnings by 55.56%, reporting an EPS of $0.04 versus an estimate of $0.09.

Revenue was up $353 thousand from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 6.54% drop in the share price the next day.

Here's a look at OptimizeRx's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.01	0.20	0.13	0.07
EPS Actual	-0.01	0.22	0.09	0.10
Revenue Estimate	13.97M	20.16M	15.06M	12.45M
Revenue Actual	13.73M	20.31M	16.12M	13.63M

To track all earnings releases for OptimizeRx visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.